| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 11/24/2010 | EP1539739B1 Piperidinyl compounds that selectively bind integrins |
| 11/23/2010 | US7838289 Assay utilizing multipotent adult stem cells |
| 11/18/2010 | US20100292252 Vinyl-aryl derivatives for inflammation and immune-related uses |
| 11/18/2010 | US20100291174 Biologically active device and method for its production |
| 11/18/2010 | US20100291055 Surgical hydrogel |
| 11/16/2010 | US7833525 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 11/11/2010 | US20100286793 Device for minimally invasive plastic surgery lift procedure |
| 11/11/2010 | US20100285113 Enhanced stability of inverse thermal gelling composite hydrogels |
| 11/11/2010 | US20100285094 Polymeric compositions and methods of making and using thereof |
| 11/11/2010 | US20100285090 biological repair of cartilage using a hybrid construct combining both an inert structure and living core;cell-matrix encapsulation devices for growing, proliferating, and/or differentiating cells into chondrocyte-like cells under mechanical stress; has inflatable/expandable balloon-like bio-polymers |
| 11/09/2010 | CA2462692C Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity |
| 11/09/2010 | CA2407659C Growth hormone secretagogues |
| 11/04/2010 | WO2010125069A1 Hyaluronic acid for preventing post surgical adhesions |
| 11/04/2010 | US20100279982 Cellulose derivative |
| 11/04/2010 | US20100279960 Biotinylated hexadecasaccharides, preparation and use thereof |
| 11/04/2010 | US20100278895 Antioxidants and antimicrobial accessories including antioxidants |
| 11/04/2010 | US20100278894 Antioxidants and antimicrobial accessories including antioxidants |
| 10/28/2010 | WO2010122787A1 Peritoneum-protecting agent and method for producing peritoneum-protecting agent |
| 10/21/2010 | WO2010119994A1 Polysaccharide derivative and hydrogel thereof |
| 10/21/2010 | CA2758907A1 Polysaccharide derivative and hydrogel thereof |
| 10/20/2010 | CN101361751B Moisture absorption self-adhesion barrier film capable of preventing postoperative adhesions and preparation method thereof |
| 10/20/2010 | CN101164530B Aqueous solution containing stable sodium pyrouvate and preparing method and use thereof |
| 10/19/2010 | CA2458853C Use of fucans in the treatment of adhesions, arthritis and psoriasis |
| 10/14/2010 | US20100260822 Surface protection of exposed biological tissues |
| 10/14/2010 | US20100260819 Reducing post-operative adhesion formation with intraperitoneal glutamine |
| 10/12/2010 | US7811991 Polypeptide therapeutic for treating ischemia associated with perioperative surgical procedure |
| 10/07/2010 | US20100255101 Dextran-based polymer tissue adhesive for medical use |
| 10/07/2010 | US20100255068 Hair-like shaped hydrogels for soft tissue augmentation |
| 10/07/2010 | US20100255058 Biocompatible polyacrylate compositions for medical applications |
| 10/06/2010 | EP2236152A1 Albumin fusion proteins |
| 10/06/2010 | EP1451193B1 Podophyllotoxins as antiproliferative agents |
| 10/05/2010 | US7807659 5-Fluoro-4-oxo-3-[1-(substituted-carbonyl)-2-piperidinecarboxamido]-pentanoic acid derivatives such as [3S/R (2S)]-5-Fluoro-4-oxo-3-[1-(2-phenyl-thiazole-4-carbonyl)-2-piperidinecarboxamido]-pentanoic acid, used for the treatment of bone disorders, inflammatory, autoimmune and degenerative diseases |
| 09/30/2010 | WO2010111137A2 Method for suppressing or preventing fibrous adhesion formation using a multicomponent aqueous oxychlorine composition prepared on-site |
| 09/30/2010 | WO2010064806A3 Composition for preventing adhesion |
| 09/30/2010 | CA2756695A1 Method for suppressing or preventing fibrous adhesion formation using a multicomponent aqueous oxychlorine composition prepared on-site |
| 09/29/2010 | EP2233145A1 A dose of AVE5026 for the treatment of venous thromboembolism in patients with severe renal impairment |
| 09/29/2010 | CN101848739A Surgical hydrogel |
| 09/29/2010 | CN101848724A Use of TRL-2 antagonists for treatment of reperfusion injury and tissue damage |
| 09/29/2010 | CN101125149B Ophthalmic operating special-purpose colored perfusate |
| 09/23/2010 | WO2010106519A1 A dose of ave5026 for the treatment of venous thromboembolism in patients with severe renal impairment |
| 09/23/2010 | US20100240607 Dextrin-containing composition for preventing surgical adhesions |
| 09/23/2010 | CA2755726A1 A dose of ave5026 for the treatment of venous thromboembolism in patients with severe renal impairment |
| 09/22/2010 | CN101837006A Application of PCL-PEG-PCL tri-block copolymer in preparation of medical anti-blocking material |
| 09/21/2010 | CA2401502C Carboxylic acid derivatives as ip antagonists |
| 09/16/2010 | US20100234465 Administration of Intravenous Ibuprofen |
| 09/16/2010 | US20100233238 Medical Devices Having Nanoporous Coatings for Controlled Therapeutic Agent Delivery |
| 09/14/2010 | CA2294711C Novel polymeric compositions |
| 09/08/2010 | EP2226385A1 Human Coagulation Factor VII Variants |
| 09/08/2010 | EP2226075A1 Material for preventing tissue adhesion and material for preventing joint contracture |
| 09/08/2010 | CN101822643A Ligustrazine nanoparticle, preparation method and pharmaceutical application thereof |
| 09/02/2010 | WO2010097595A1 Compositions for use in cardioplegia comprising esmolol and adenosine |
| 08/31/2010 | US7785599 Albumin fusion proteins |
| 08/26/2010 | WO2010095304A1 Hydrogel of polysaccharide derivatives |
| 08/26/2010 | US20100216871 Use of compounds having ccr antagonism |
| 08/26/2010 | CA2752720A1 Hydrogel of polysaccharide derivative |
| 08/25/2010 | EP2219546A1 Endoscopic mucosal resectioning using purified inverse thermosensitive polymers |
| 08/18/2010 | CN101808509A Improved organ protection, preservation and recovery |
| 08/18/2010 | CN101804066A Application of MPEG-PLA (Methoxypolyethylene Glycols-Polylactic Acid) diblock copolymers in preparation of medical anti-blocking material |
| 08/17/2010 | CA2431974C Urea and urethane derivatives as integrin inhibitors |
| 08/12/2010 | US20100204087 Tribonectins |
| 08/11/2010 | EP2216409A1 Albumin fusion proteins |
| 08/11/2010 | EP1531791B1 Prevention and reduction of ischemia |
| 08/05/2010 | WO2010087521A1 Combined preparation for treating joint diseases |
| 08/05/2010 | US20100197566 Method and Apparatus for Preparing an Acellular Red Blood Cell Substitute |
| 08/05/2010 | US20100196442 Methods for treating open wounds |
| 08/04/2010 | EP2213743A1 Albumin fusion proteins |
| 08/03/2010 | US7767223 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use |
| 07/29/2010 | US20100189686 Albumin Fusion Proteins |
| 07/28/2010 | CN1923198B Use of kurarinone in preparation of medicine for postoperative intestine functional restoration |
| 07/28/2010 | CN1905875B The use of quaternary pyridinium salts as vasoprotective agents |
| 07/27/2010 | CA2435425C A suspension comprising fibrinogen, thrombin and alcohol, a method for preparing such a suspension, a method for coating a carrier with such a suspension, a method of drying a coating of a carrier, and a coated collagen sponge |
| 07/22/2010 | WO2010082531A1 Active blood coagulation factor inhibitor |
| 07/20/2010 | US7759323 Highly purified antiendotoxin compound |
| 07/20/2010 | CA2547234C The use of quaternary pyridinium salts as vasoprotective agents |
| 07/14/2010 | EP2206720A1 Albumin fusion proteins |
| 07/08/2010 | DE102009003980A1 Propofol in triheptanoinhaltiger Trägeremulsion Propofol emulsion carrier in triheptanoinhaltiger |
| 07/07/2010 | CN101766650A Washing liquor for operation and method for preparing same |
| 07/01/2010 | WO2010072684A1 Norrin in the treatment of diseases associated with an increased tgf-beta activity |
| 07/01/2010 | US20100166834 Preparations based on fibrinogen and sulfated polysaccharides |
| 06/22/2010 | US7740830 Imaging, diagnosis and treatment of disease |
| 06/16/2010 | EP2195039A1 Surgical hydrogel |
| 06/15/2010 | US7737214 cross-linking polysaccharide derivative containing at least one active ester group introduced in a polysaccharide side chain, which is capable of reacting with an active hydrogen-containing group; avoid risks as caused by using a non-biologically derived material |
| 06/10/2010 | WO2010064806A2 Composition for preventing adhesion |
| 06/10/2010 | US20100144818 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof |
| 06/10/2010 | CA2743920A1 Composition for preventing adhesion |
| 06/09/2010 | EP1497273B1 Hydroxamic acid derivatives |
| 06/09/2010 | CN101721423A Bicarbonate physiological balanced solution and preparation method thereof |
| 06/03/2010 | US20100137191 Protective agents for transplanted organs |
| 06/02/2010 | CN101716185A Anti-adhesion agent and preparation process thereof |
| 05/27/2010 | US20100129419 Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation |
| 05/25/2010 | CA2353679C Procedure and installation for the dynamic packaging of gases, specifically for medical use |
| 05/11/2010 | US7713725 Using expression vector containing inducible regulatory sequences associated with cellulase transcription to control expression of heterologous nucleotide sequences in cells; identifying glucanase activators |
| 05/06/2010 | US20100113471 2-Aminoaryloxazole compounds as tyrosine kinase inhibitors |
| 05/06/2010 | US20100112063 Method for preparing a hydrogel adhesive having extended gelation time and decreased degradation time |
| 05/05/2010 | EP1267894B1 Viscoelastics for use in middle ear surgery |
| 04/29/2010 | US20100105628 Reducing post-operative adhesion formation with intraperitoneal glutamine |
| 04/29/2010 | US20100105603 Methods and Preparations For Curing Clinically Ill Patients |
| 04/29/2010 | US20100104542 Cell transplantation |
| 04/29/2010 | US20100104539 Placental tissue grafts and improved methods of preparing and using the same |
| 04/27/2010 | CA2468479C Podophyllotoxins as antiproliferative agents |